Cargando…
A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor
Vanin-1 is an amidohydrolase that catalyses the conversion of pantetheine into the amino-thiol cysteamine and pantothenic acid (coenzyme A precursor), which plays a vital role in multiple physiological and pathological processes. In this study, an enzyme-activated near-infrared (NIR) fluorescent pro...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799884/ https://www.ncbi.nlm.nih.gov/pubmed/35127388 http://dx.doi.org/10.1016/j.apsb.2021.06.004 |
_version_ | 1784642146429566976 |
---|---|
author | Tian, Zhenhao Yan, Fei Tian, Xiangge Feng, Lei Cui, Jingnan Deng, Sa Zhang, Baojing Xie, Tian Huang, Shanshan Ma, Xiaochi |
author_facet | Tian, Zhenhao Yan, Fei Tian, Xiangge Feng, Lei Cui, Jingnan Deng, Sa Zhang, Baojing Xie, Tian Huang, Shanshan Ma, Xiaochi |
author_sort | Tian, Zhenhao |
collection | PubMed |
description | Vanin-1 is an amidohydrolase that catalyses the conversion of pantetheine into the amino-thiol cysteamine and pantothenic acid (coenzyme A precursor), which plays a vital role in multiple physiological and pathological processes. In this study, an enzyme-activated near-infrared (NIR) fluorescent probe (DDAV) has been constructed for sensitively detecting Vanin-1 activity in complicated biosamples on the basis of its catalytic characteristics. DDAV exhibited a high selectivity and sensitivity toward Vanin-1 and was successfully applied to the early diagnosis of kidney injury in cisplatin-induced kidney injury model. In addition, DDAV could serve as a visual tool for in situ imaging endogenous Vanin-1 in vivo. More importantly, Enterococcus faecalis 20247 which possessed high expression of Vanin-1 was screened out from intestinal bacteria using DDAV, provided useful guidance for the rational use of NSAIDs in clinic. Finally, oleuropein as a potent natural inhibitor for Vanin-1 was discovered from herbal medicines library using a high-throughput screening method using DDAV, which held great promise for clinical therapy of inflammatory bowel disease. |
format | Online Article Text |
id | pubmed-8799884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87998842022-02-03 A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor Tian, Zhenhao Yan, Fei Tian, Xiangge Feng, Lei Cui, Jingnan Deng, Sa Zhang, Baojing Xie, Tian Huang, Shanshan Ma, Xiaochi Acta Pharm Sin B Original Article Vanin-1 is an amidohydrolase that catalyses the conversion of pantetheine into the amino-thiol cysteamine and pantothenic acid (coenzyme A precursor), which plays a vital role in multiple physiological and pathological processes. In this study, an enzyme-activated near-infrared (NIR) fluorescent probe (DDAV) has been constructed for sensitively detecting Vanin-1 activity in complicated biosamples on the basis of its catalytic characteristics. DDAV exhibited a high selectivity and sensitivity toward Vanin-1 and was successfully applied to the early diagnosis of kidney injury in cisplatin-induced kidney injury model. In addition, DDAV could serve as a visual tool for in situ imaging endogenous Vanin-1 in vivo. More importantly, Enterococcus faecalis 20247 which possessed high expression of Vanin-1 was screened out from intestinal bacteria using DDAV, provided useful guidance for the rational use of NSAIDs in clinic. Finally, oleuropein as a potent natural inhibitor for Vanin-1 was discovered from herbal medicines library using a high-throughput screening method using DDAV, which held great promise for clinical therapy of inflammatory bowel disease. Elsevier 2022-01 2021-06-08 /pmc/articles/PMC8799884/ /pubmed/35127388 http://dx.doi.org/10.1016/j.apsb.2021.06.004 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Tian, Zhenhao Yan, Fei Tian, Xiangge Feng, Lei Cui, Jingnan Deng, Sa Zhang, Baojing Xie, Tian Huang, Shanshan Ma, Xiaochi A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title | A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title_full | A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title_fullStr | A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title_full_unstemmed | A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title_short | A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
title_sort | nir fluorescent probe for vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799884/ https://www.ncbi.nlm.nih.gov/pubmed/35127388 http://dx.doi.org/10.1016/j.apsb.2021.06.004 |
work_keys_str_mv | AT tianzhenhao anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT yanfei anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT tianxiangge anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT fenglei anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT cuijingnan anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT dengsa anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT zhangbaojing anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT xietian anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT huangshanshan anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT maxiaochi anirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT tianzhenhao nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT yanfei nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT tianxiangge nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT fenglei nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT cuijingnan nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT dengsa nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT zhangbaojing nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT xietian nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT huangshanshan nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor AT maxiaochi nirfluorescentprobeforvanin1anditsapplicationsinimagingkidneyinjurydiagnosisandthedevelopmentofinhibitor |